One of the primary goals of the ECOG-ACRIN Health Equity Committee is to continue addressing disparities that limit the representation of minority populations in cancer clinical trials, according to Edith P. Mitchell, MD (Thomas Jefferson University). “African Americans have the highest rates of cancer mortality [compared with] any other group in the country. [It is important to] evaluate and contribute information to other groups regarding specific cancers,” Dr. Mitchell said. “For example, for Native Americans, there is a higher incidence of liver cancer and hepatocellular carcinomas. It is [about] understanding all of the groups so that we are incorporating those factors into our clinical trials during their development.”